NRG1 and myopia: The differences in vitreous cavity length between the right eyes and left eyes were significantly and dose-dependently elevated in the NRG-1 antibody groups compared with the myopia group (low-dose NRG-1 antibody group: p = 0.08; medium-dose NRG-1 antibody group: p = 0.002; high-dose NRG-1 antibody group: p = 0 < 0.001) (Table 1; Figure 2F).